ACA
Avoro Capital Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $196M | Buy |
4,150,000
+1,379,900
| +50% | +$65.1M | 3.43% | 9 |
|
|
2025
Q1 | $108M | Hold |
2,770,100
| – | – | 1.69% | 17 |
|
|
2024
Q4 | $150M | Hold |
2,770,100
| – | – | 2.12% | 15 |
|
|
2024
Q3 | $140M | Buy |
2,770,100
+100
| +0% | +$5.04K | 2.04% | 16 |
|
|
2024
Q2 | $122M | Buy |
2,770,000
+190,000
| +7% | +$8.35M | 1.62% | 17 |
|
|
2024
Q1 | $130M | Hold |
2,580,000
| – | – | 1.51% | 21 |
|
|
2023
Q4 | $156M | Buy |
2,580,000
+580,001
| +29% | +$35M | 2.15% | 17 |
|
|
2023
Q3 | $114M | Buy |
1,999,999
+274,999
| +16% | +$15.7M | 1.78% | 16 |
|
|
2023
Q2 | $88M | Buy |
+1,725,000
| New | +$88M | 1.19% | 19 |
|